Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.38 AUD | +14.57% |
|
+13.08% | +8.62% |
Jun. 28 | Clinuvel Pharmaceuticals Limited Announces Change of Company Secretary | CI |
Jun. 24 | Clinuvel Pharmaceuticals Secures Orphan Drug Designation in Europe for Metabolic Disorder Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.62% | 587M | |
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
-55.41% | 8.97B |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Clinuvel Pharmaceuticals Treats First Patient in Phase Two Stroke Trial